GeneralMedium•6 November 2026•
1 min read
CMS Formalizes Medicare Drug Price Negotiation Rules Under IRA
Key Facts
1The Centers for Medicare & Medicaid Services (CMS) issued a final rule formalizing the drug price negotiation process established by the Inflation Reduction Act.
The Centers for Medicare & Medicaid Services (CMS) issued a final rule formalizing the drug price negotiation process established by the Inflation Reduction Act. Fierce Pharma reported that the move transitions the program from initial guidance into a formal regulatory framework.
The action solidifies the implementation of the mandate for government negotiation of prices for specific high-cost drugs. The formalization of these rules is expected to maintain long-term pricing pressure on the healthcare sector.